Biontech Se Stock Market Value
| BNTX Stock | USD 92.20 0.08 0.09% |
| Symbol | BioNTech |
BioNTech SE Price To Book Ratio
Is BioNTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share 0.51 | Revenue Per Share 11.369 | Quarterly Revenue Growth (0.85) | Return On Assets (0.01) |
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioNTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioNTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioNTech.
| 04/16/2024 |
| 05/16/2024 |
If you would invest 0.00 in BioNTech on April 16, 2024 and sell it all today you would earn a total of 0.00 from holding BioNTech SE or generate 0.0% return on investment in BioNTech over 30 days. BioNTech is related to or competes with Novavax, Ginkgo Bioworks, Crispr Therapeutics, Ocean Biomedical, Enveric Biosciences, Hepion Pharmaceuticals, and Elevation Oncology. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseas... More
BioNTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioNTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioNTech SE upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 9.89 | |||
| Value At Risk | (2.65) | |||
| Potential Upside | 2.21 |
BioNTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioNTech's standard deviation. In reality, there are many statistical measures that can use BioNTech historical prices to predict the future BioNTech's volatility.| Risk Adjusted Performance | 0.0053 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioNTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioNTech SE Backtested Returns
We consider BioNTech very steady. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.0135, which signifies that the company had a 0.0135% return per unit of risk over the last 3 months. We have found twenty-one technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please confirm BioNTech's Risk Adjusted Performance of 0.0053, mean deviation of 1.24, and Standard Deviation of 1.58 to double-check if the risk estimate we provide is consistent with the expected return of 0.0205%. BioNTech has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioNTech's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioNTech is expected to be smaller as well. BioNTech SE right now shows a risk of 1.52%. Please confirm BioNTech SE variance, skewness, as well as the relationship between the Skewness and price action indicator , to decide if BioNTech SE will be following its price patterns.
Auto-correlation | -0.08 |
Very weak reverse predictability
BioNTech SE has very weak reverse predictability. Overlapping area represents the amount of predictability between BioNTech time series from 16th of April 2024 to 1st of May 2024 and 1st of May 2024 to 16th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioNTech SE price movement. The serial correlation of -0.08 indicates that barely 8.0% of current BioNTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.99 |
BioNTech SE lagged returns against current returns
Autocorrelation, which is BioNTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioNTech's stock expected returns. We can calculate the autocorrelation of BioNTech returns to help us make a trade decision. For example, suppose you find that BioNTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioNTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioNTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioNTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioNTech stock over time.
Current vs Lagged Prices |
| Timeline |
BioNTech Lagged Returns
When evaluating BioNTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioNTech stock have on its future price. BioNTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioNTech autocorrelation shows the relationship between BioNTech stock current value and its past values and can show if there is a momentum factor associated with investing in BioNTech SE.
Regressed Prices |
| Timeline |
Pair Trading with BioNTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioNTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will appreciate offsetting losses from the drop in the long position's value.Moving against BioNTech Stock
| 0.56 | ACB | Aurora Cannabis Financial Report 12th of June 2024 | PairCorr |
The ability to find closely correlated positions to BioNTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioNTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioNTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioNTech SE to buy it.
The correlation of BioNTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioNTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioNTech SE moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioNTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out BioNTech Correlation, BioNTech Volatility and BioNTech Alpha and Beta module to complement your research on BioNTech. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.